Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 101 - 125 of 4933 in total
Disorders such as schizophrenia and bipolar disorder can significantly impair mood, cognition, and behavior. These mental illnesses can often be accompanied by comorbidities such as depression and substance abuse, and can significantly impact the quality of life of patients and caregivers. Luckily, several treatment options for psychotic disorders have been...
Approved
Matched Iupac: … 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one …
Matched Products: … ZELDOX 60 MG ... ZELDOX (CAPSULES 60 MG) ... ZIPRASIDON-NEURAX 60 MG …
Imiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist. Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas. Imiquimod does not cure warts, and new warts may appear during treatment. Imiquimod does not fight the viruses that...
Approved
Investigational
Matched Products: … ALDARA %5 KREM, 6 SAŞE …
Tiaprofenic acid is a non-steroidal anti-inflammatory drug employed in the treatment of pain, particularly arthritis pain. It belongs to the arylpropionic acid (profen) group of nonsteroidal anti-inflammatory drugs (NSAIDs).
Approved
Matched Products: … SURGAM 300 MG SUPOZITUVAR, 6 ADET …
Oxolamine is not approved in the USA, it may be marketed elsewhere internationally as a cough suppressant . It is listed as a prescription drug in New Zealand legislation . Oxolamine is also approved in Taiwan for the treatment of respiratory tract inflamation .
Approved
Matched Mixtures name: … KATARIN FORT 650 MG/200 MG/60 MG/4 MG FİLM KAPLI TABLET, 20 ADET ... OLEDRO HOT D TEK DOZLUK EFERVESAN GRANÜL İÇEREN POŞET, 6 ADET ... OLEDRO HOT TEK DOZLUK EFERVESAN GRANÜL İÇEREN POŞET, 6 ADET …
Dyphylline is a theophylline derivative with broncho- and vasodilator properties. It is typically used in the management of asthma, cardiac dyspnea, and bronchitis.
Approved
Matched Products: … ENJEKSİYONLUK ÇÖZELTİ, 6 AMPUL …
Morphine, the main alkaloid of opium, was first obtained from poppy seeds in 1805. It is a potent analgesic, though its use is limited due to tolerance, withdrawal, and the risk of abuse. Morphine is still routinely used today, though there are a number of semi-synthetic opioids of varying strength...
Approved
Investigational
Matched Salts cas: … 52-26-6 ... 596-15-6
Matched Products: … M BETA 60 ... .-60 Tab 60mg ... M STADA 60 MG RET …
Eflornithine is an irreversible ornithine decarboxylase inhibitor originally developed as a treatment for human African trypanosomiasis. Further research has also implicated ornithine decarboxylase in other conditions like facial hirsutism and cancer, especially when ornithine decarboxylase is highly upregulated in tumor cells.[A4112, A262834] Additionally, ornithine decarboxylase is activated by c-myc or...
Approved
Withdrawn
Matched Salts cas: … 96020-91-6
Matched Products: … EFLORİN %13.9 KREM, 60 GRAM …
Magaldrate is an antacid drug used for the treatment of esophagitis, duodenal and gastric ulcers, and gastroesophageal reflux. Magaldrate has been discontinued in the US market.
Approved
Withdrawn
Matched Mixtures name: … ASIDOPAN PLUS 60 CIGNEME TABLET ... SİMELGAT PLUS ÇİĞNEME TABLETİ, 60 ADET ... ASIPODAN PLUS FORTE ÇIĞNEME TABLETI, 60 ADET …
Matched Products: … ASIPODAN ÇIĞNEME TABLETI, 60 ADET …
Exenatide is a glucagon-like peptide-1 (GLP-1) analog . It activates the GLP-1 receptor and increases insulin secretion, decreases glucagon secretion, and slows gastric emptying to improve glycemic control . Exenatide was given FDA approval on April 28, 2005 . It is available as immediate- and extended-release formulations.[L42685,L42690] Bydureon, the brand...
Approved
Investigational
Matched Products: … BYETTA 5 µG/20 µL SC KULLANIMA HAZIR DOLU ENJEKSİYON KALEMI ICINDE COZELTI, 1.2 ML (60 DOZ) ... BYETTA 10 µG/40 µL SC KULLANIMA HAZIR DOLU ENJEKSİYON KALEMI ICINDE COZELTI, 2.4 ML (60 DOZ) …
Calcipotriol (INN) or calcipotriene (USAN) is a sythetic derivative of calcitriol or Vitamin D.
Approved
Matched Mixtures name: … NuDermRxPAK 60 ... NuDermRxPAK 60
Matched Products: … Calcipotriene 0.005% 60 gram Foam ... PSORCUTAN 0,05 MG/ML SCALP ÇÖZELTİ , 60 ML …
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Approved
Matched Mixtures name: … SOLIQUA® 30-60
Matched Products: … LYXUMIA 20 MCG ENJEKSIYON IÇIN ÇÖZELTI IÇEREN KULLANIMA HAZIR KALEM ,6 KALEM …
Pyrantel is a pyrimidine-derivative anthelmintic agent for the oral treatment of various parasitic worm infections including ascariasis, hookworm infections, enterobiasis (pinworm infection), trichostrongyliasis, and trichinellosis . Pyrantel was initially described in 1965 by researchers from Pfizer who sought cyclic amidines with suitable pharmacokinetic properties (specifically, duration of action) for use...
Approved
Vet approved
Matched Salts cas: … 22204-24-6
Matched Products: … ASKOL ÇIĞNEME TABLETI, 6 ADET ... KONTIL 250 MG ÇİĞNEME TABLETİ, 6 ADET …
Loxoprofen is a propionic acid derivative non-steroidal anti-inflammatory drug. It is marketed under the trade name Loxonin in Brazil, Mexico and Japan by Sankyo, as Loxomac in India, and as Oxeno in Argentina. A transdermal preparation was approved for use in Japan in January 2006.
Approved
Matched Salts cas: … 80382-23-6
Matched Products: … LOXONIN 60 MG …
Apalutamide is a potent androgen receptor (AR) antagonist that selectively binds to the ligand-binding domain of AR and blocks AR nuclear translocation or binding to androgen response elements . It has been used in trials studying the treatment of Prostate Cancer, Hepatic Impairment, Prostatic Neoplasms, Castration-Resistant Prostate Cancer, and Prostatic...
Approved
Investigational
Matched Iupac: … 4-{7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl}-2 …
Matched Products: … ERLEADA ®TABLETAS RECUBIERTAS 60 MG …
Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States.
Approved
Investigational
Matched Products: … LEDASON 60 MG FİLM KAPLI TABLET, 30 ADET ... LUİGON 60 MG FİLM KAPLI TABLET, 30 ADET ... LURADİN 60 MG FİLM KAPLI TABLET, 30 ADET …
Iothalamic acid is an iodine containing organic anion used as a diagnostic contrast agent.
Approved
Matched Products: … Conray 60
Indacaterol is a novel, ultra-long-acting, rapid onset β(2)-adrenoceptor agonist developed for Novartis for the once-daily management of asthma and chronic obstructive pulmonary disease. It was approved by the European Medicines Agency (EMA) on 30 November 2009 and by the FDA on 1 July 2011. It is marketed in Europe as...
Approved
Matched Products: … ARCAPTA 150 MCG INHALER KAPSÜL,60 ADET ... INBROXA 150 MCG İNHALASYON TOZU, SERT KAPSÜL, 60 KAPSÜL ... ONBREZ BREEZHALER 150 MCG INHALER KAPSÜL, 60 KAPSÜL …
Nifedipine, or BAY a 1040, is a first generation dihydropyridine L-type calcium channel blocker, similar to nicardipine.[A190210,A190273,A175390,L11383] Nifedipine was developed by Bayer and first described in the literature, along with other dihydropyridines, in 1972.[A175390,A190276] Since nifedipine's development, second and third generation dihydropyridines have been developed with slower onsets and longer...
Approved
Matched Products: … ADALAT LA 60 TABLET 60 mg ... ADALAT CR 60 ... CARDIOSOL® 60 MG …
Approved
Experimental
Matched Categories: … Fatty Acids, Omega-6
Linagliptin is a DPP-4 inhibitor developed by Boehringer Ingelheim for the treatment of type II diabetes . Linagliptin differs from other DPP-4 inhibitors in that it has a non-linear pharmacokinetic profile, is not primarily eliminated by the renal system, and obeys concentration dependant protein binding . Linagliptin was approved by...
Approved
Matched Products: … TRAJENTA DUO 2.5MG/1000MG FILM KAPLI TABLET, 60 ADET ... TRAJENTA DUO 2.5MG/850MG FILM KAPLI TABLET, 60 ADET …
Artesunate is indicated for the initial treatment of severe malaria. The World Health Organization recommends artesunate as first line treatment for severe malaria. Artesunate was developed out of a need for a more hydrophilic derivative of artemisinin. Artesunate was granted FDA approval on 26 May 2020.
Approved
Investigational
Matched Products: … ARTESUN POWDER FOR INJECTION 60 MG …
Pregabalin is structurally similar to gamma-aminobutyric acid (GABA) - an inhibitory neurotransmitter. It may be used to manage neuropathic pain, postherpetic neuralgia, and fibromyalgia among other conditions. Although as per the FDA Label the mechanism of action has not been definitively characterized, there is evidence that pregabalin exerts its effects...
Approved
Investigational
Matched Mixtures name: … PAGAMAX PLUS 75 MG/1 MG KAPSÜL ,60 KAPSÜL ... PAGAMAX PLUS 150 MG/1 MG KAPSÜL ,60 KAPSÜL ... PAGAMAX PLUS 300 MG/1 MG KAPSÜL ,60 KAPSÜL …
Matched Products: … PRECOBAL 75 MG/1 MG KAPSÜL, 60 ADET ... NORAFIT 25 MG EFERVESAN TABLET, 60 ADET ... NORAFIT 75 MG EFERVESAN TABLET, 60 ADET …
Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Approved
Investigational
Matched Mixtures name: … TB VIT 6 ... RIMACTAZID ® PAED 60 / 60 COMPRIMIDOS. …
Bilastine is a novel new-generation antihistamine that is highly selective for the H1 histamine receptor, has a rapid onset and prolonged duration of action.
Approved
Investigational
Matched Products: … Olisir 6 mg/ml Augentropfen, Lösung …
Recombinant stabilized RSV B prefusion F antigen is one component of a bivalent respiratory syncytial virus (RSV) vaccine called Abrysvo. The vaccine comprises two antigens - the other being recombinant stabilized RSV A prefusion F antigen - which have been expressed in Chinese hamster ovary cell lines and then purified...
Approved
Matched Description: … [L48066] Abrysvo was first approved by the FDA in May 2023 for use in patients ≥60 years of age, and …
Displaying drugs 101 - 125 of 4933 in total